2023-03-29 13:05:12 TA TravelCenters
Arko Corp.
03/29/23 03/2913:05 03/29/2313:05 | Arko says 'riskless' to TravelCenters' holders for board to engage on proposalARKO Corp. (ARKO) issued a letter to TravelCenters of America's (TA) board, setting forth additional details of ARKO's financing in connection with its proposal to acquire TravelCenters, and again asking for TravelCenters' engagement with ARKO in the sale process. The letter discloses a second amendment to ARKO's Standby Real Estate Purchase, Designation and Lease Program agreement with Oak Street, a Division of Blue Owl Capital, in which Oak Street has agreed, subject to the terms contained in the Program Agreement, to provide for an additional $1.25B of capacity specifically to finance ARKO's acquisition of TravelCenters. "In addition to the additional capacity provided by the amended Program Agreement, ARKO has significant additional liquidity through cash, cash equivalents, and availability under its existing credit lines. ARKO has never required any financing conditions and has closed every acquisition it has put under contract. ARKO's proposal to TravelCenters offers no financing-related conditions. TravelCenters' Board has refused to engage at all with ARKO since ARKO originally submitted, on March 14, 2023, a superior proposal of $92 a share, a nearly 7% premium to the $86 per share price pursuant to TravelCenters' existing merger agreement with BP Products North America Inc., a wholly owned indirect subsidiary of BP p.l.c. ARKO's proposal was further improved on March 27, 2023, including ARKO's willingness to pre-pay $202 million for 11 years of lease payments, using the same discount rate as BP's proposal, in comparison to BP's proposal to pre-pay $188 million for 10 years of lease payments. ARKO believes it is riskless to TravelCenters' stockholders for TravelCenters' Board to engage with ARKO, and that doing so could reasonably be expected to lead to a superior proposal. ARKO has retained financial and legal advisors for this transaction and believes this update merits immediate engagement by TravelCenters's Board, management, and advisors... ARKO's track record, strong financial position, and confidence in obtaining financing for this transaction should be seriously considered by TravelCenters' Board and management when assessing whether ARKO's superior proposal is in the best interests of TravelCenters' stockholders. ARKO is prepared to immediately commence confirmatory due diligence and quickly enter into an Agreement and Plan of Merger along with the other ancillary arrangements on the same material terms as in the Merger Agreement with BP," the company stated in a press release. TravelCenters
Arko Corp.
BP
|
---|
Initiation
|
iRhythm assumed with an Overweight at Morgan Stanley »
06:58 05/30/23 05/3006:58 05/30/2306:58
IRTC
iRhythm
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Axonics assumed with an Overweight at Morgan Stanley »
06:58 05/30/23 05/3006:58 05/30/2306:58
AXNX
Axonics
Morgan Stanley assumed… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Insperity price target lowered to $120 from $131 at Baird »
06:57 05/30/23 05/3006:57 05/30/2306:57
NSP
Insperity
Baird analyst Mark Marcon… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Sight Sciences assumed with an Overweight at Morgan Stanley »
06:57 05/30/23 05/3006:57 05/30/2306:57
SGHT
Sight Sciences
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Insulet assumed with an Equal Weight at Morgan Stanley »
06:56 05/30/23 05/3006:56 05/30/2306:56
PODD
Insulet
Morgan Stanley assumed… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
DexCom assumed with an Equal Weight at Morgan Stanley »
06:56 05/30/23 05/3006:56 05/30/2306:56
DXCM
DexCom
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
TransMedics assumed with an Equal Weight at Morgan Stanley »
06:55 05/30/23 05/3006:55 05/30/2306:55
TMDX
TransMedics
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Hibbett price target lowered to $50 from $70 at Baird »
06:55 05/30/23 05/3006:55 05/30/2306:55
HIBB
Hibbett
Baird lowered the… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Teleflex assumed with an Equal Weight at Morgan Stanley »
06:54 05/30/23 05/3006:54 05/30/2306:54
TFX
Teleflex
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Edwards Lifesciences assumed with an Overweight at Morgan Stanley »
06:54 05/30/23 05/3006:54 05/30/2306:54
EW
Edwards Lifesciences
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
ShockWave Medical assumed with an Equal Weight at Morgan Stanley »
06:53 05/30/23 05/3006:53 05/30/2306:53
SWAV
ShockWave Medical
Morgan Stanley assumed… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Lincoln Electric price target raised to $200 from $184 at Baird »
06:53 05/30/23 05/3006:53 05/30/2306:53
LECO
Lincoln Electric
Baird analyst Mircea… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Boston Scientific assumed with an Overweight at Morgan Stanley »
06:52 05/30/23 05/3006:52 05/30/2306:52
BSX
Boston Scientific
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Bausch + Lomb assumed with an Equal Weight at Morgan Stanley »
06:52 05/30/23 05/3006:52 05/30/2306:52
BLCO
Bausch + Lomb
Morgan Stanley assumed… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Alcon assumed with an Equal Weight at Morgan Stanley »
06:51 05/30/23 05/3006:51 05/30/2306:51
ALC
Alcon
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Google AI chip orders accelerating at Broadcom, says JPMorgan »
06:50 05/30/23 05/3006:50 05/30/2306:50
AVGO
Broadcom
Alphabet
Alphabet
Meta Platforms
JPMorgan analyst Harlan… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Pfizer's marstacimab shows significant efficacy in Phase 3 hemophilia trial »
06:49 05/30/23 05/3006:49 05/30/2306:49
PFE
Pfizer
Pfizer announced that the… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Baxter assumed with an Equal Weight at Morgan Stanley »
06:48 05/30/23 05/3006:48 05/30/2306:48
BAX
Baxter
Morgan Stanley assumed… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Becton Dickinson assumed with an Overweight at Morgan Stanley »
06:48 05/30/23 05/3006:48 05/30/2306:48
BDX
Becton Dickinson
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Team regains NYSE compliance »
06:47 05/30/23 05/3006:47 05/30/2306:47
TISI
Team
Team announced that it… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Golden Minerals to effect 1-for-25 reverse stock split »
06:46 05/30/23 05/3006:46 05/30/2306:46
AUMN
Golden Minerals
Golden Minerals announced… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
PayPal recent weakness should be bought, says Mizuho »
06:45 05/30/23 05/3006:45 05/30/2306:45
PYPL
PayPal
Mizuho analyst Dan Dolev… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Lantheus selloff on competitor approval overdone, says Mizuho »
06:42 05/30/23 05/3006:42 05/30/2306:42
LNTH
Lantheus
Mizuho views… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Omega Healthcare price target lowered to $31 from $32 at Mizuho »
06:39 05/30/23 05/3006:39 05/30/2306:39
OHI
Omega Healthcare
Mizuho analyst Vikram… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Ventas price target lowered to $53 from $60 at Mizuho »
06:39 05/30/23 05/3006:39 05/30/2306:39
VTR
Ventas
Mizuho analyst Vikram… Story temporarily locked. ShowHide Related Items >><<
|